Market Research Analysis Cardiac Marker Testing Market Analysis and Share | Page 2

and obesity. However, factors such as technical problems related to collection of samples and storage and issues in
relation to regulatory and reimbursement systems are key factors hindering growth of the market.
Developing countries such as India and China have proved to be popular for companies developing cardiac biomarkers.
Prevalence of cardiovascular diseases are significant in driving growth of cardiac biomarker testing market. China is
top nation in CVD mortality rates and of importance here is that biomarkers help in early diagnosis of disease and
hence help doctors and clinicians around the world with technological advances among doctors and clinicians talked
in seminars are propelling demand for cardiac biomarkers in emerging markets.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/cardiac-marker-testing-market/request-sample
Segmentation of cardiac marker testing market by type includes Troponin CK MB, MYoglobin, Brain Naturerteic
peptide or NTpro BNPandC-reactive protein. By product, cardiac marker testing market includes instruments,
chemiluminiscence, imunoflursecence, ELISA and reagents and kits.By disease, cardiac marker testing market includes
myocardial infection and congestive heart failure. By type of testing, cardiac marker testing market includes laboratory
testing and point-of-care testing.By geographical regions, cardiac marker testing market includes North America,
Europe, Asia pacific, MEA and Latin America. North America holds largest share of cardiac marker testing market
followed by Europe. Asia Pacific is expected to gain maximum lead in markets in forecast period.
Cardiac biomarker tests measure the concentration of certain proteins called biomarkers which indicate the severity
of cardiovascular disease. Among the most prominent of CVD are sudden cardiac arrest (SCA), acute myocardial
infection (AMI), congestive heart failure (CHF) and atherosclerosis. The most attractive of cardiac marker growth areas
include the cardiac rapid assay market. Key players have entered into agreements, partnerships and have embarked
on product launches and showcased products to ensure market dominance. The key industry players in cardiac marker
testing market include Roche Diagnostics, Abott Laboratories and Siemens AG, Danahe Corporation, LSI MED science
Corporation.
Market Segment:
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million
USD), market share and growth rate of Cardiac Marker Testing in these regions, from 2013 to 2025 (forecast),
covering
• North America
• Europe
• China